A Randomized Multicenter Phase III Study of Cisplatin Plus Radiotherapy Compared to Cetuximab Plus Radiotherapy in Locally Advanced Head and Neck Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
The primary endpoint in this study is to investigate if there is a difference in overall survival in patients with locally advanced head and neck cancer, randomized to either radiotherapy and cetuximab or radiotherapy and cisplatin. A second randomization is performed in patients with T3-T4 tumors; allocated radiotherapy either 68.0 Gy or 73.1 Gy.
Epistemonikos ID: 50f86b8c02d7b047df1c289ebfe4cb498993bb04
First added on: May 11, 2024